Enhanced Evaluation for Minimizing Physical Restraint: New Deductions and Additions in the FY2026 Medical Fee Revision (February 13, 2026) - Shakaihoken Kenkyusho

SUMMARY

According to Google News reports on the medical fee revision, "Enhanced Evaluation for Minimizing Physical Restraint: New Deductions and Additions in the FY2026 Medical Fee Revision (February 13, 2026) – Shakaihoken Kenkyusho" has been announced. This information is relevant for management decisions in hospitals, clinics, and medical corporations as a latest trend in the healthcare industry.

📝 EDITOR'S NOTE — A Medical M&A Perspective

In the FY2026 medical fee revision,"Minimizing Physical Restraint"is being strengthened through both additions and deductions, signifying that consideration for human rights in medical settings has transformed into a "financial risk" that impacts the core of management.has transformed into "financial risk"For medical institutions where restraint has become normalized due to chronic staff shortages, this regulatory change could critically impact their revenue structure.

From an M&A perspective in the medical field, "restraint utilization rates" and "alternative measure consideration processes" will be added to due diligence items. Facilities facing deduction risks may be deemed to have uncertain future revenue projections, potentially lowering their valuation during business succession. Conversely, facilities that have already implemented ICT monitoring systems to achieve zero restraint will likely attract stronger interest from buyers as "high-quality assets" due to their superior operational standards.

Executives facing succession issues should re-evaluate their institution's care quality using objective metrics. If establishing such systems independently is challenging, integrating with a group hospital that possesses educational resources and capacity for system investment becomes a realistic option to enhance regulatory compliance and protect both staff and patients.

News Highlights

The FY2026 Medical Fee Revision will strengthen evaluations for minimizing physical restraint, introducing new deductions and additions. This suggests the importance of a medium- to long-term perspective, considering the revision cycle, in the management and business succession strategies of medical institutions. Furthermore, maintaining facility standards through economies of scale, dispersing the burden of capital investment, and utilizing tax schemes including transitions to specific medical corporations or social medical corporations can also be points of discussion in business succession.

M&A Medical Editorial Department’s Perspective

The concretization of minimizing physical restraint as an evaluation item in this medical fee revision can be seen not only as an improvement in the quality of care but also as an incentive for operational efficiency. Particularly, as staffing and care plan reviews become necessary, adapting to these new evaluation items may require certain capital investments and personnel training. For example, the introduction of monitoring sensors or the creation of individualized care plans through multidisciplinary collaboration can be considered. For small to medium-sized medical institutions in particular, addressing these initiatives alone may pose a burden. Grouping through M&A can be an effective means to disperse these upfront investment burdens and promote the sharing of specialized personnel and the adoption of the latest technologies. Moreover, as the minimization of physical restraint gains attention as a management indicator, the evaluation criteria for medical institutions may change in the future, making it essential to build a management system capable of adapting to such changes in medium- to long-term business succession strategies.

Points Raised by This News

The establishment of new evaluations for minimizing physical restraint encourages the alignment of medical institutions’ care models and management strategies.
Responding to new evaluation items necessitates capital investment and personnel training.
Small to medium-sized medical institutions should consider expanding their scale through M&A if standalone responses are difficult.
Trends in medical fee revisions indicate potential changes in future evaluation criteria for medical institutions.

Practical Questions Arising from This News

What are the specific guidelines for capital investment and staffing to minimize physical restraint?
What is the expected impact on revenue from the introduction of new deductions and additions?
How will the status of initiatives to minimize physical restraint be evaluated during due diligence in M&A?

If You Feel “Should I Consult Too?”

The evaluation of minimizing physical restraint in this medical fee revision may affect your institution’s current care system, staffing, and future capital investment plans. If you feel that adapting to the new evaluation standards will be a management burden, or if staff shortages or securing specialized personnel are issues, expanding business scale through M&A or strengthening the management base by joining a group can be effective options. Please consult with experts to consider the optimal business succession and growth strategy based on your institution’s current situation and future plans.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a completely success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation here

📌 Source (Primary Information)

Enhanced Evaluation for Minimizing Physical Restraint: New Deductions and Additions in the FY2026 Medical Fee Revision (February 13, 2026) – Shakaihoken Kenkyusho

Source: Google News: Medical Fee Revision

Please see the original article for details

Regarding trends in medical institutions like this case,

we provide a detailed explanation of the 'Medical Succession Guide'

Read the Complete Guide →